Recent 15
Launch of research-use reagent "LecChip® 45-uni" for glycan profiling analysis
(90.0 KB)2023:07:03:13:00:00Consolidated Financial Results for Second Quarter of the FY2023 (July 1, 2022 to December 31, 2022) [Japanese GAAP]
(136.3 KB)2023:02:14:18:00:00Consolidated Financial Results for First Quarter of the FY2023 (July 1, 2022 to September 30, 2022) [Japanese GAAP]
(135.6 KB)2022:11:11:18:00:00Consolidated Financial Results for the FY2022 (July 1, 2022 to June 30, 2022) [Japanese GAAP]
(142.7 KB)2022:08:12:18:00:00"ELITe InGenius", a fully automated RT-PCR analyzer of ELITechGroup sells over 1,000 units to date
(205.6 KB)2022:01:05:17:30:00Re: OEM supply of "ELITe BeGenius", fully automated molecular diagnostics platform for ELITechGroup
(258.2 KB)2021:10:05:16:00:00Consolidated Financial Results for First Quarter of the FY2021 (July 1, 2020 to September 30, 2020) [Japanese GAAP]
(152.2 KB)2020:11:13:19:50:20Letter of Appreciation from the Ambassador of France for our contribution in supplying the fully automated PCR testing system
(106.1 KB)2020:04:24:16:00:00SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS Fiscal Year, Ending June 30, 2019
(334.6 KB)2019:10:28:15:00:00Notice Regarding Revision of Consolidated Earnings Forecast
(92.5 KB)2019:08:13:10:00:00SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For Three Months of the Fiscal Year, Ending June 30, 2019
(246.1 KB)2019:01:09:12:00:00PSS Announces launch of geneLEAD VIII in Europe - PSS forms European sales alliance with Diagenode -
(243.0 KB)2018:10:29:18:30:01SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS Fiscal Year, Ended June 30, 2018
(278.5 KB)2018:10:12:16:26:48PSS basically agreed with ELITech on new development and supply of the system (on an OEM basis)
(162.9 KB)2018:08:10:09:00:00Notice on commercial launch of geneLEAD VIII, fully automated molecular diagnostic system
(246.0 KB)2018:07:13:14:15:00